NICE Guidance
 
 
 

Latest Updates:

 
Resolor PI Information

Resolor PI Information

Find the latest Prescribing Information for Resolor 1mg & Resolor 2mg.

Click here to view.
PSUK Terms with Shire

PSUK Terms with Shire

The Shire MDS scheme, including Resolor.

Available to PSUK Dispensing Doctor Members only, please sign in to view.
 
Boost on Resolor

Boost on Resolor

Consider Resolor and save money!

Available to PSUK Dispensing Doctor Members only, please sign in to view.
NICE Guidance
TA211 - Prucalopride for the treatment of chronic constipation in women1

Resolor:

Prucalopride is recommended as an option for the treatment of chronic constipation only in women for whom treatment with at least two laxatives from different classes, at the highest tolerate recommended doses for at least 6 months, has failed to provide adequate relief and invasive treatment for constipation is being considered.

If treatment with prucalopride is not effective after 4 weeks, the woman should be re-examined and the benefit of continuing treatment reconsidered.

Prucalopride should only be prescribed by a clinician with experience of treating chronic constipation who has carefully reviewed the woman's previous courses of laxative treatments specified in the first point above.

NICE assessed cost-effectiveness and advised that Resolor is an appropriate use of NHS resources

TA211 Costing Template (from Nice.org.uk) >

References
1. National Institute for Clinical Excellence. TA211 Constipation (women) - Prucalopride guidance. 15 December 2010 (Accessed 16 December 2010).

Please note that Practice Services UK and/or Shire Pharmaceuticals cannot be held responsible for the content of external links.
 
Charities and Patient Information
Please note that Practice Services UK and/or Shire Pharmaceuticals Ltd can not be held responsible for the content of external link
 
NHS Clinical Knowledge Summaries
Please note that Practice Services UK and/or Shire Pharmaceuticals Ltd can not be held responsible for the content of external link
 
Journals
Please note that Practice Services UK and/or Shire Pharmaceuticals Ltd can not be held responsible for the content of external link
 
Useful Links
Please note that Practice Services UK and/or Shire Pharmaceuticals Ltd can not be held responsible for the content of external link